ClinicalTrials.govpublic full text
IFx-Hu2.0 Expanded Access Program
cutaneous melanoma, stage iii, cutaneous melanoma, stage iv, merkel cell carcinoma, cutaneous squamous cell carcinoma, cm, mcc, cscc, pdna, plasmid dna, pac/emm55, ifx-hu.20, immunotherapy
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 911874
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.